Benchmark: End-Stage Renal Disease Payment System Updates for 2025

Take this benchmark to assess how much you would benefit from taking the course on the Medicare Program; End-Stage Renal Disease Prospective Payment System Final Rule (CY 2025). In a few minutes, you’ll gauge how well you grasp the intent and operational impact of the rule—what changes are meant to achieve, who is most affected, and the trade-offs you’ll need to manage across payment, quality, and access. You’ll see where your understanding is strong and where deeper learning would reduce compliance risk, protect revenue, and improve patient access and outcomes. If your answers tend to focus on old assumptions (hospital wage index, in-center only AKI care, Part D-only oral drugs) or miss the equity and attribution implications (home dialysis expansion, refined transplant failure identification, measure-topic scoring), the course will help you translate policy into concrete actions: update billing and IT, adapt staffing and inventory for oral medications, align quality reporting, and anticipate financial impacts by geography and volume. Use this benchmark to decide whether you need the full course now or just a targeted refresher on PPS payment mechanics, QIP changes, ETC attribution, and compliance steps.